308 related articles for article (PubMed ID: 24113307)
1. Translocation-associated salivary gland tumors: a review and update.
Weinreb I
Adv Anat Pathol; 2013 Nov; 20(6):367-77. PubMed ID: 24113307
[TBL] [Abstract][Full Text] [Related]
2. [New developments in molecular diagnostics of carcinomas of the salivary glands: "translocation carcinomas"].
Skálová A; Šteiner P; Vaneček T
Cesk Patol; 2016; 52(3):139-45. PubMed ID: 27526014
[TBL] [Abstract][Full Text] [Related]
3. Fusion oncogenes in salivary gland tumors: molecular and clinical consequences.
Stenman G
Head Neck Pathol; 2013 Jul; 7 Suppl 1(Suppl 1):S12-9. PubMed ID: 23821214
[TBL] [Abstract][Full Text] [Related]
4. [Advances in genetics and pathology of salivary gland tumors].
Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Apr; 47(4):193-8. PubMed ID: 22800695
[No Abstract] [Full Text] [Related]
5. [A new analysis tool of salivary gland tumors: looking for specific translocations].
Uro-Coste E
Ann Pathol; 2011 Nov; 31(5 Suppl):S100-2. PubMed ID: 22054439
[No Abstract] [Full Text] [Related]
6. WIF1, an inhibitor of the Wnt pathway, is rearranged in salivary gland tumors.
Queimado L; Lopes CS; Reis AM
Genes Chromosomes Cancer; 2007 Mar; 46(3):215-25. PubMed ID: 17171686
[TBL] [Abstract][Full Text] [Related]
7. [Determination of DNA content in salivary gland tumors].
Yáñez M; Roa I; Villaseca M; Fuentealba P
Rev Med Chil; 1997 Oct; 125(10):1177-81. PubMed ID: 9609036
[TBL] [Abstract][Full Text] [Related]
8. Mammaglobin and S-100 immunoreactivity in salivary gland carcinomas other than mammary analogue secretory carcinoma.
Patel KR; Solomon IH; El-Mofty SK; Lewis JS; Chernock RD
Hum Pathol; 2013 Nov; 44(11):2501-8. PubMed ID: 24029710
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of runt-related transcription factor 3 associated with poor prognosis of adenoid cystic and mucoepidermoid carcinomas of the salivary gland.
Sasahira T; Kurihara M; Yamamoto K; Bhawal UK; Kirita T; Kuniyasu H
Cancer Sci; 2011 Feb; 102(2):492-7. PubMed ID: 21105967
[TBL] [Abstract][Full Text] [Related]
10. Mammary analog secretory carcinoma of salivary gland origin with the ETV6 gene rearrangement by FISH: expanded morphologic and immunohistochemical spectrum of a recently described entity.
Connor A; Perez-Ordoñez B; Shago M; Skálová A; Weinreb I
Am J Surg Pathol; 2012 Jan; 36(1):27-34. PubMed ID: 21989350
[TBL] [Abstract][Full Text] [Related]
11. Reevaluation of MAML2 fusion-negative mucoepidermoid carcinoma: a subgroup being actually hyalinizing clear cell carcinoma of the salivary gland with EWSR1 translocation.
Hsieh MS; Wang H; Lee YH; Ko JY; Chang YL
Hum Pathol; 2017 Mar; 61():9-18. PubMed ID: 27769871
[TBL] [Abstract][Full Text] [Related]
12. [Phenotype-genotype correlations in salivary gland tumors. Status of molecular analysis].
Röser K; Löning T
Laryngorhinootologie; 2001 Nov; 80(11):639-41. PubMed ID: 11702271
[No Abstract] [Full Text] [Related]
13. Expression of ras-P21 in salivary gland tumors.
Kusama K; Chu L; Suzuki T; Okutsu S; Kudo I; Moro I
Adv Exp Med Biol; 1995; 371B():1187-90. PubMed ID: 7502781
[No Abstract] [Full Text] [Related]
14. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
15. Salivary gland cancers: biology and molecular targets for therapy.
Bell D; Hanna EY
Curr Oncol Rep; 2012 Apr; 14(2):166-74. PubMed ID: 22246609
[TBL] [Abstract][Full Text] [Related]
16. New developments in the molecular pathogenesis of head and neck tumors: a review of tumor-specific fusion oncogenes in mucoepidermoid carcinoma, adenoid cystic carcinoma, and NUT midline carcinoma.
Bhaijee F; Pepper DJ; Pitman KT; Bell D
Ann Diagn Pathol; 2011 Feb; 15(1):69-77. PubMed ID: 21238915
[TBL] [Abstract][Full Text] [Related]
17. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
O'Neill ID
Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
[TBL] [Abstract][Full Text] [Related]
18. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
19. Clinical implication of CD166 expression in salivary gland tumor.
Andisheh-Tadbir A; Ashraf MJ; Khademi B; Ahmadi S
Tumour Biol; 2015 Apr; 36(4):2793-9. PubMed ID: 25472586
[TBL] [Abstract][Full Text] [Related]
20. Utility of mammaglobin immunohistochemistry as a proxy marker for the ETV6-NTRK3 translocation in the diagnosis of salivary mammary analogue secretory carcinoma.
Bishop JA; Yonescu R; Batista D; Begum S; Eisele DW; Westra WH
Hum Pathol; 2013 Oct; 44(10):1982-8. PubMed ID: 23773480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]